MENU

COYA Stock Tickeron detected bullish Stock Pattern: Triangle Descending COYA on June 23, 2025, netting in a 16.92% gain over 3 weeks

A.I.dvisor
at Tickeron.com
Loading...
+16.92% Gain from a Successful pattern Triangle Descending
COYA - Coya Therapeutics
Tickeron
Ticker: COYA
Company: Coya Therapeutics
Gain: +16.92%
Confirmed: 06/23/25
Succeeded: 07/09/25
Total length: 22 days
On June 17, 2025, A.I.dvisor detected a Triangle Descending Pattern (Bullish) for Coya Therapeutics (COYA, $5.32). On June 23, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $6.42. 16 days later, on July 09, 2025, COYA reached the target price resulting in a +1 for traders who took a long position in the stock.

COYA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for COYA turned positive on June 23, 2025. Looking at past instances where COYA's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 25, 2025. You may want to consider a long position or call options on COYA as a result. In of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

COYA moved above its 50-day moving average on July 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COYA crossed bullishly above the 50-day moving average on July 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COYA advanced for three days, in of 130 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COYA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COYA broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COYA entered a downward trend on June 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.171) is normal, around the industry mean (17.368). P/E Ratio (0.000) is within average values for comparable stocks, (59.372). COYA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.445). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (27.100) is also within normal values, averaging (273.506).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5850 San Felipe Street
Phone
+1 800 587-8170
Employees
8
Web
https://www.coyatherapeutics.com